Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim

Contributed by: Business Wire

Logo

Tags

Data Management

Biotechnology

Technology

Health

Pharmaceutical

Oncology

Health Technology

Research

Software

Artificial Intelligence

Science

Owkin

More Like This

Owkin to License K Pro and Multimodal Data to Servier to Advance Oncology Research

K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making.

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi

ACCESS Newswire associated0

Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models

Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca

Owkin Brings Biology Super Intelligence Closer to Reality with New AI Infrastructure for Biological Breakthroughs

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research